Metformin for Type 2 as Good as New Expensive Drugs
By Kathleen Blanchard RN for EmaxHealth.com
Johns Hopkins researchers compared newer diabetes drugs that are more costly to metformin that has been on the market for 15 years. They found metformin has fewer side effects and found no evidence that brand name newer drugs to treat type 2 diabetes are any better.
Metformin has Fewer Side Effects, Controls Blood Sugar
In the analysis most of the diabetes drugs controlled blood sugar levels, but newer diabetes drugs were found to increase the risk of dangerous side effects.
The researchers investigated diabetes drugs in 2007. As a follow-up study, they added two newer types of diabetes drugs for comparison to metformin – Byetta and Victoza that are given by injection.
Dr. Wendy Bennett, an assistant professor of medicine at Johns Hopkins University School of Medicine in Baltimore, the study’s lead author said, “Metformin continues to be an inexpensive medication and it’s very efficacious.”
To continue reading this article, crash on over here.